In-Vivo Proteins Essentials [CATALOG]
L L • August 24, 2021
Solid-phase oligonucleotide synthesis remains the backbone of therapeutics, with flow-enabled SPOS delivering unmatched control, scalability, and regulatory reliability.
AI promises to transform biotech, but real-world results are more incremental. A practical perspective on AI in drug discovery, genomics, diagnostics, and lab automation.
Discover kbDNA’s rapid workflow for repurifying rituximab biosimilars to high-purity standards—featuring SEC overlays, gel schematics, and SOPs.
